Loss of ADAR1 in tumor cells activates cDC1s and sensitizes pancreatic cancer to immunotherapy
RNA-seq (gene expression) · mouse · 14 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 14 samples: 4 × pancreatic cancer, sgControl, vs 4 × pancreatic cancer, sgADAR1, vs 3 × FC1199, sgControl+IFNγ, vs 3 × FC1199, sgADAR1+IFNγ,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE289275_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1222324 and SRA study SRP563173. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 4 samples read as cases, 3 as controls.
How we read this: 4 replicated groups read from 14 sample titles; they account for 14 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8788237 FC1199, sgControl+IFNγ, rep1 FC1199, sgControl+IFNγ,
- GSM8788238 FC1199, sgControl+IFNγ, rep2 FC1199, sgControl+IFNγ,
- GSM8788239 FC1199, sgControl+IFNγ, rep3 FC1199, sgControl+IFNγ,
- GSM8788240 FC1199, sgADAR1+IFNγ, rep1 FC1199, sgADAR1+IFNγ,
- GSM8788241 FC1199, sgADAR1+IFNγ, rep2 FC1199, sgADAR1+IFNγ,
- GSM8788242 FC1199, sgADAR1+IFNγ, rep3 FC1199, sgADAR1+IFNγ,
- GSM8788243 pancreatic cancer, sgControl, rep1 pancreatic cancer, sgCo…
- GSM8788244 pancreatic cancer, sgControl, rep2 pancreatic cancer, sgCo…
- GSM8788245 pancreatic cancer, sgControl, rep3 pancreatic cancer, sgCo…
- GSM8788246 pancreatic cancer, sgControl, rep4 pancreatic cancer, sgCo…
- GSM8788247 pancreatic cancer, sgADAR1, rep1 pancreatic cancer, sgAD…
- GSM8788248 pancreatic cancer, sgADAR1, rep2 pancreatic cancer, sgAD…
- GSM8788249 pancreatic cancer, sgADAR1, rep3 pancreatic cancer, sgAD…
- GSM8788250 pancreatic cancer, sgADAR1, rep4 pancreatic cancer, sgAD…
- GSE234570 GGNBP2 regulates MDA5 sensing triggered by self double stranded RNA following loss of ADAR1 editing 95 samples shares adar1, loss
- GSE311488 Chemotherapeutic Induction of Single-Stranded DNA Accumulation Sensitizes Triple-Negative Breast Cancer to Immunotherapy [scRNA-seq] 32 samples shares immunotherapy, sensitizes
- GSE306986 Synergistic Stromal Remodeling and Dual Chemo-Immunotherapy in Pancreatic Cancer: A Two-Stage Losartan-Primed followed Nanocarrier Strategy for Tumor Microenvironment Reprogramming 24 samples shares immunotherapy, pancreatic
- GSE315303 Pygo2 Loss Induces Tertiary Lymphoid Structure Formation and Enhances Immunotherapy and Castration Responses in Prostate Cancer 22 samples shares immunotherapy, loss
- GSE288530 Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis 18 samples shares sensitizes, pancreatic
- GSE275780 Dual Targeting of STING and PI3Kγ Eliminates Regulatory B Cells to Overcome STING Resistance for Pancreatic Cancer Immunotherapy [RNA-seq] 17 samples shares immunotherapy, pancreatic
- GSE297817 Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy [DASAITC] 15 samples shares immunotherapy, sensitizes
- GSE300887 Sequential Platinum and PARP Inhibition Enhances PD1 Immunotherapy Efficacy in Murine Brca2 Mutated Pancreatic Cancer [RNAseq_1] 13 samples shares immunotherapy, pancreatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.